ARLEN G. FLEISHER, M.D.; FRED KIMMELSTIEL, M.D.; CONRAD G. LATTES, M.D.; ROBERT E. MILLER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Cecchine and Panarello (1) in differing with Kerr and coauthors (2) suggest that a protracted course with an appropriate agent may be useful for the treatment of patients with fungal peritonitis without necessitating removal of a permanent peritoneal catheter.
If not promptly treated, peritonitis, manifested by abdominal pain, tenderness, fever, cloudy dialysate, elevated leukocyte count in the dialysate, and positive dialysate cultures, remains a significant and potentially life-threatening complication. In many cases peritonitis can be successfully treated with intraperitoneal or intravenous plus intraperitoneal antibiotic agents.
Between 1980 and 1983, of 47 patients with peritonitis secondary to indwelling
FLEISHER AG, KIMMELSTIEL F, LATTES CG, et al. Fungal Peritonitis and Peritoneal Catheters. Ann Intern Med. 1985;102:138. doi: https://doi.org/10.7326/0003-4819-102-1-138_2
Download citation file:
Published: Ann Intern Med. 1985;102(1):138.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use